Live biotherapeutic/Microbiome Based Therapeutics Market Size, Share & Trends Analysis Report By Product (VOWST (SER-109), REBYOTA, Visbiome, Other Pipeline Products), By Route of Administration (Oral Therapeutics, Rectal Therapeutics), By Target Disease Indication (Recurrent C. Difficile Infection, Dietary Management of Microbial Imbalance, Other Indications), By Distribution Channel, By End User, By Region, And Segment Forecasts, 2025-2034

Explore our pricing plans

Single User License

$4456
  • PDF Report and Excel Datasheet
  • Delivered in 24-72 hrs. of purchase
  • Access for one individual only
  • Analyst support up to 3 Months
Purchase Now

Multi-User License

$7786
  • PDF Report, Excel Datasheet and Power BI
  • Delivered in 24-72 hrs. of purchase
  • Access for 5-6 individuals only
  • Analyst support up to 3 Months
Purchase Now

Corporate License

$10000
  • PDF Report, Excel Datasheet and Power BI
  • Delivered in 24-72 hrs. of purchase
  • Unlimited access for all employees within the organization
  • Analyst support up to 6 Months
Purchase Now

Quantitative Data Access

$1200
  • PowerBI/Excel Pivot Dashboard
  • Excel Datasheet and Power BI
  • Delivered in 24-72 hrs. of purchase
  • Unlimited access for all employees within the organization
  • Analyst support up to 6 Months
Purchase Now